Sildenafil May Block Cancer Metastasis by Trapping Cholesterol, Preclinical Study Finds

A new study led by researchers at the Weizmann Institute of Science查看公司主页 in Israel suggests that sildenafil查看药品详情, the active ingredient in Viagra, may interfere with cancer (搜索)搜索该疾病's ability to spread by disrupting cholesterol regulation inside cells. The findings, published in the journal Cancer Research, bridge laboratory discoveries with real-world patient data from Israel's largest health organization, Clalit Health Services查看公司主页.

"We have uncovered a new biological pathway that links a well-known signaling molecule to cholesterol regulation within cells, and shown how this pathway can be harnessed to interfere with the ability of cancer (搜索)搜索该疾病 cells to form metastases," said study leader Ayelet Erez, according to the Weizmann Institute.

How Sildenafil查看药品详情 Disrupts Cancer (搜索)搜索该疾病 Cell Migration

The research team identified a previously unknown mechanism through which sildenafil查看药品详情 affects cholesterol trafficking. Cancer (搜索)搜索该疾病 cells depend on cholesterol to build and organize their outer membranes, which must bend and reorganize as cells detach from a primary tumor, crawl through surrounding tissue, enter the bloodstream, and invade distant organs.

Sildenafil查看药品详情 works by blocking an enzyme called phosphodiesterase type 5 (PDE5 (搜索)搜索该靶点), which raises levels of cyclic GMP (cGMP), a signaling molecule that relaxes blood vessels. The new research reveals that elevated cGMP can bind to proteins responsible for ferrying cholesterol out of cellular compartments. When these proteins falter, cholesterol piles up inside them instead of reaching the rest of the cell where it is needed for invasion.

In laboratory experiments, this cholesterol depletion damaged cholesterol-rich membrane structures and caused cancer (搜索)搜索该疾病 cells to migrate less effectively and form fewer metastases in mouse models. The effect appeared to impact cancerous cells more than healthy cells.

A Two-Drug Strategy with Statins (搜索)搜索该药品

When sildenafil查看药品详情 trapped cholesterol inside cellular compartments, cancer (搜索)搜索该疾病 cells activated a molecular emergency system called SREBP2—a cholesterol thermostat that orders the cell to manufacture more cholesterol when usable supplies fall. This compensatory response suggested a potential vulnerability.

The researchers combined sildenafil查看药品详情, which blocked the release of stored cholesterol, with statins (搜索)搜索该药品, which suppress new cholesterol production. In both laboratory and animal experiments, the combination produced a stronger anti-metastatic effect than either approach alone.

Real-World Evidence from Patient Records

To assess whether these laboratory findings might translate to human outcomes, scientists from Clalit Health Services查看公司主页 analyzed more than 20 years of anonymized medical records from approximately 5 million participants, including an observational study of 40,000 males diagnosed with cancer (搜索)搜索该疾病.

Male participants who had used sildenafil查看药品详情 before their cancer (搜索)搜索该疾病 diagnosis had better overall survival rates than those who had not taken the drug. The survival association appeared even stronger for males who took both sildenafil and statins (搜索)搜索该药品.

"This study bridges two worlds," said Samah Hayek, MD, senior epidemiologist at the Clalit Research Institute and a co-author of the study. "The laboratory identified a promising biological mechanism while Clalit's real-world data showed that the same signal may also be reflected in patient outcomes."

Limitations and Cautions

The researchers were careful to delineate the study's boundaries. The analysis did not specify whether sildenafil查看药品详情 would be more effective against certain cancer (搜索)搜索该疾病 types. "We evaluated the association between pre-cancer diagnosis use and overall survival across a large cohort of cancer patients rather than within specific cancer types," Hayek noted. "Therefore, we cannot conclude whether the association is stronger for one cancer than another."

The study also could not determine whether sildenafil查看药品详情 would benefit women. "Our retrospective analysis included mainly men because sildenafil is predominantly prescribed to men," Hayek said. "As a result, we cannot determine from our clinical data whether a similar association would be observed in women."

Crucially, the survival benefit was observed only in patients who had taken sildenafil查看药品详情 before their cancer (搜索)搜索该疾病 diagnosis. "Our study did not examine whether giving Viagra to patients after they are diagnosed with cancer improves outcomes," Hayek emphasized. "These findings are encouraging, but they do not mean cancer patients should start taking Viagra."

Expert Perspectives

Independent experts expressed cautious optimism while underscoring the need for prospective clinical trials.

"These results are preclinical—meaning the data were derived from cell lines or mice," said Mike Lattanzi, MD, a medical oncologist and director of the Genitourinary Cancer (搜索)搜索该疾病 Research Program at Texas Oncology. "They are intriguing and thought-provoking, but they would need to be validated in human studies in order to inform the management of cancer patients."

S. Adam Ramin, MD, a urologist and urologic oncologist at Urology Cancer (搜索)搜索该疾病 Specialists in Los Angeles, described the study as "well-designed" and noted it "appears to have real applications in real-world situations, so it shows promise."

Ramkishen Narayanan, MD, director of the Center for Urologic Health at The Roy and Patricia Disney Family Cancer (搜索)搜索该疾病 Center, added: "The basic science mechanism of potential anti-tumorigenic activity using the cholesterol biosynthesis pathway is exciting, especially when currently widely available medications may have a serendipitous role in cancer treatment."

Lattanzi also noted that cancer (搜索)搜索该疾病 cells can develop "escape mechanisms" to elude certain therapies, and that researchers are "a long way off from developing any kind of cancer prevention, or so-called chemoprevention strategy, utilizing drugs like these."

The Path Forward

Drug repurposing efforts like this one offer potential advantages: sildenafil查看药品详情 has been used by millions of people, and researchers already understand much about its manufacturing, dosing, and side-effect profile. However, the next steps require randomized clinical trials that assign patients to treatment or placebo and track recurrence, metastasis, and survival. Those studies must determine which cancers respond, when treatment should begin, and whether sildenafil works best before surgery, after surgery, or alongside existing therapies.

"Beyond their therapeutic promise, our findings highlight that cancer (搜索)搜索该疾病 biology is shaped not only by mutations in tumor cells but also by the patient's metabolic state and by medications they are already taking for other conditions," Erez said.